An evaluation of 6 placebo-controlled medical trials with 1,134 overall individuals concluded that cannabinoids (nabiximols, dronabinol, and THC/CBD) were being related to a greater typical advancement about the Ashworth scale for spasticity in numerous sclerosis patients when compared with placebo, Even though this didn't access statistical import… Read More

This Article is Under Review… Read More